Inactivated vaccines

vaccine to prevent poliomyelitis

vaccine to prevent Hepatitis A

vaccine against influenza

vaccine that is effective at preventing cholera

group of vaccines against infection of humans and animals with the rabies virus

vaccine protecting against whooping cough

Chinese inactivated virus candidate vaccine against COVID-19

any of several vaccines against Japanese encephalitis

vaccines that uses the killed version of the germ that causes a disease

preventive medicine

vaccine rusa

COVID-19 vaccine developed by Iranian state-owned Shifa Pharmed Industrial Group

vaccine candidate against COVID-19

vaccine against COVID-19

Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) and patented in September 2006.

Turkovac (pronunciation: Help:IPA/Turkish|) is a COVID-19 vaccine developed by Turkish Ministry of Health and Erciyes University. __TOC__ == Clinical trials == In November 2020, Turkovac started on phase I trials with 44 participants in Turkey.

FAKHRAVAC () is a COVID-19 vaccine developed in Iran by the Organization of Defensive Innovation and Research, a subsidiary of Iran's Ministry of Defense. It is the third Iranian COVID-19 vaccine reaching clinical trials. It is currently in phase III. It received emergency use authorization in Iran on 9 September 2021.

vaccine candidate against COVID-19

vaccine candidate against COVID-19